139 related articles for article (PubMed ID: 34921671)
1. Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Hara K; Maezawa Y; Hashimoto I; Suematsu H; Watanabe H; Komori K; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2023 Mar; 54(1):27-34. PubMed ID: 34921671
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
Aoyama T; Komori K; Nakazano M; Hara K; Tamagawa H; Kazama K; Hashimoto I; Yamada T; Maezawa Y; Segami K; Kano K; Nagasawa S; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2022; 36(2):942-948. PubMed ID: 35241553
[TBL] [Abstract][Full Text] [Related]
4. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
5. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Anticancer Res; 2018 Aug; 38(8):4877-4882. PubMed ID: 30061263
[TBL] [Abstract][Full Text] [Related]
6. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
7. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
9. The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kamiya N; Kato A; Yamada T; Nagasawa S; Kawahara S; Cho H; Morita J; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
Anticancer Res; 2023 Nov; 43(11):5181-5187. PubMed ID: 37909998
[TBL] [Abstract][Full Text] [Related]
10. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
11. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
12. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
13. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
15. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection.
Deng J; Liang H; Sun D; Pan Y
J Surg Res; 2010 Jun; 161(1):47-53. PubMed ID: 19783008
[TBL] [Abstract][Full Text] [Related]
16. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
[TBL] [Abstract][Full Text] [Related]
17. Life prognosis of sentinel node navigation surgery for early-stage gastric cancer: Outcome of lymphatic basin dissection.
Kinami S; Nakamura N; Miyashita T; Kitakata H; Fushida S; Fujimura T; Iida Y; Inaki N; Ito T; Takamura H
World J Gastroenterol; 2021 Dec; 27(46):8010-8030. PubMed ID: 35046627
[TBL] [Abstract][Full Text] [Related]
18. The patterns and timing of recurrence after curative resection for gastric cancer in China.
Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
20. The clinical impacts of the prognostic nutritional index for the esophageal cancer patients who received curative treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
